Research & Innovation - Participant Portal

TOPIC : Exploitation of IMI project results

Topic identifier: IMI2-2017-11-01
Publication date: 19 July 2017

Types of action: IMI2-RIA Research and Innovation action
DeadlineModel:
Opening date:
single-stage
19 July 2017
Deadline: 24 October 2017 17:00:00

Time Zone : (Brussels time)
  Horizon 2020
Topic Description
Specific Challenge:

A key challenge of any research funding scheme is to ensure that significant results, outputs and/or data generated during the lifetime of a project remain available to be further exploited for maximum beneficial impact after the project finishes. Often, important scientific results reach the public domain via publication in relevant scientific journals. However, for some important results – which may include databases, biobanks, new tools, important clinical samples, demonstration models, etc. – the route to becoming available to the wider scientific community or being exploited fully, remains a difficult path. Realising the full potential of a project’s important results within the timeframe available is not always possible and might sometimes only be achieved through the involvement of additional expertise from outside of the project.

Scope:

This call for proposals aims at providing a starting/short term support to develop enabling solutions to ensure that significant results from IMI projects become fully exploitable, available to all relevant end users, and/or fully sustainable in the long term and in their own right. This will ensure that the significant outputs, important samples and/or data that have been generated by the large public-private investments are maintained and made available for future research by the whole scientific community and that important findings are integrated in general research and medical practice in support of the objectives of IMI2. The work to be supported will consist mainly of activities and measures to make the results available to the broader scientific community and as such may include measures to enable technology transfer and the analysis of regulatory aspects, as well as the standardisation and transfer of samples, databases, tools, etc. to sustainable infrastructures. In addition, the work may also encompass further activities should novel solutions/tools/methods be required to achieve the objectives of sustaining the results and ensuring their full impact. These could include adaptation of technologies to enable wider engagement, development of novel standardisation and/or interoperability measures, further development of scientific and business solutions, etc., as appropriate.

Applicants should be aware that only the project results identified in the list of results available on the IMI2 JU website http://www.imi.europa.eu/content/imi-2-call-11 are within the scope of this Call. As such, applicants must clearly indicate through their proposals which results they are utilising.

The relevant consortia will provide the necessary access rights to any potential applicant in furtherance of the call objectives and according to applicable IMI rules

Expected Impact:

It is expected that proposals selected for award under this call will lead to a sustainable future and full exploitation for key IMI project results. It is also envisaged that sustaining these results will stimulate the development of an open innovation model in biopharmaceutical research and contribute to the achievement of IMI2 objectives.

Selected proposals should demonstrate an appreciation of the impact of exploiting the results with respect to long-term sustainability; an impact on R&D, regulatory, clinical and healthcare practice, as relevant; strengthening the competitiveness and industrial leadership and/or addressing specific societal challenges, and improving European citizens' health and wellbeing, when appropriate.

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application :

The IMI2 11th Call for proposals topic text, the Annex Table A of projects results for IMI2 Call 11 as well as the Call Conditions are available here.


1. List of countries and applicable rules for funding: described in article 10(2) of Regulation N° 1290/2013 of 11 December 2013 laying down the rules for participation and dissemination in Horizon 2020 and in article 1 of the Commission Delegated Regulation (EU) N° 622/2014 of 14 February 2014.

2. Eligibility and admissibility conditions: described in the IMI2 Manual for evaluation, submission and grant awardSee also the Commission Delegated Regulation (EU) N° 622/2014 of 14 February 2014.

Proposal page limits and layout: Please refer to Part B of the standard proposal template.

3. Evaluation

Submission and evaluation process, including evaluation criteria and procedure, scoring and threshold are described in the IMI2 Manual for submission, evaluation and grant award. See also the proposal templates for your specific action in section 5, below.

4. Indicative timetable for evaluation and grant agreement:

Information on the outcome of single-stage evaluation: maximum 5 months from the final date for submission.

Signature of grant agreements: maximum 3 month from the date of informing successful applicants.


5. Provisions, proposal templates and evaluation forms:

IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):

Proposal templates are available after entering the submission tool

Standard evaluation form 

IMI2 Model Grant Agreement 

Clinical trial template – the Clinical Trial template is compulsory at stage 2 only !

6. Additional provisions:

Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.

This topic participates per default in the open access to research data pilot which aims to improve and maximise access to and re-use of research data generated by projects:

- The pilot applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available for open access and need to describe their approach in a Data Management Plan (to be provided within six months after the project start).

- Note that the evaluation phase proposals will not be evaluated more favourably because they are part of the Pilot, and will not be penalised for opting out of the Pilot.

- Projects can at any stage opt-out of the pilot.

The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
Further information on the Open Research Data Pilot is made available in the H2020 Online Manual: http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/open-access-dissemination_en.htm 

7. Additional documents:

Summary of the most relevant provisions for participating in IMI2 actions

IMI2 Annual Work Plan 2017

IMI2 Regulators Guidance tool for researchers

IMI JU derogation to H2020 Rules for Participation

Horizon 2020 Rules for Participation

Horizon 2020 Regulation of Establishment

Horizon 2020 Specific Programme
 

Submission Service

To access the Electronic Submission Service of the topic, please select the type of action that is most relevant to your proposal from the list below and click on the 'Start Submission' button. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation you will be linked to the correct entry point.

To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.

Type of Action Research and Innovation action [IMI2-RIA]
Topic Exploitation of IMI project results - IMI2-2017-11-01
Guidance on proposal submission: H2020 online manual
IT Guidance: IT help

Get support

H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.

Participant Portal FAQ – Submission of proposals.

IMI2 JU Applicants Helpdesk – contact the IMI2 Programme Office for any question related to the Call. 

National Contact Points (NCP) – 
contact your NCP for further assistance.

Research Enquiry Service
– ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

Enterprise Europe Network
– contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk
- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Contact the EIT for further assistance related to the call, topics and the content of proposals via the Contact Page on the EIT website.

IMI States Representative Group (SRG)
– contact you SRG member for assistance.

Ethics – for compliance with ethical issues, see the Participant Portal and Science and Society Portal

European IPR Helpdesk
assists you on intellectual property issues

CEN
and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at research@cencenelec.eu.

The European Charter for Researchers and the Code of Conduct for their recruitment


Partner Search Services
help you find a partner organisation for your proposal

IMI Partner Search Tool
helps you find a partner organisation for your proposal